Elicio Therapeutics, Inc. (NASDAQ:ELTX)
| Market Cap | 36.99M-79.6% |
| Revenue (ttm) | 0 |
| Net Income | -37.84M+30.7% |
| EPS | -2.13+47.7% |
| Shares Out | 19.07M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 515,823 |
| Open | 1.67 |
| Previous Close | 1.67 |
| Day's Range | 1.67 - 1.97 |
| 52-Week Range | 1.44 - 16.00 |
| Beta | 1.98 |
| Analysts | Buy |
| Price Target | 11.83(+509.79%) |
| Earnings Date | Nov 12, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About ELTX
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
$ELTX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ELTX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ELTX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ELTX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ELTX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ELTX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ELTX
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $756.03K |
| IWMiShares Russell 2000 ETF | $516.92K |
| VXFVanguard Extended Market ETF | $261.34K |
| IWOiShares Russell 2000 Growth ETF | $203.49K |
| VTWOVanguard Russell 2000 ETF | $170.85K |
| IWCiShares Micro-Cap ETF | $80.82K |
Estimated from each fund’s disclosed top holdings × AUM
ELTX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ELTX’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.